Johnson & Johnson Needs Time To Consolidate (Technical Analysis And Downgrade)
Johnson & Johnson's long-term prospects are promising due to strong drug pipeline developments and significant R&D ...
CoreWeave Scales Back Ambitions for Its I.P.O.
The company, which originally expected its shares to be priced between $47 and $55, will ask for $40 a share in a sign of ...
CoreWeave prices IPO at a downsized $40 a share, raising $1.5 billion
Microsoft Corp. (MSFT) is, by far, CoreWeave's largest customer. Earlier this month, CoreWeave announced a deal worth up to $11.9 billion to provide AI infrastructure to OpenAI. This content was ...